Cardiac stimulator and defibrillator

• US 6,442,425 B1
• Filed: 11/15/1999
• Issued: 08/27/2002
• Est. Priority Date: 08/01/1997
• Status: Expired due to Term

• Current Assignee: Eckhard Alt
• Original Assignee: Intermedics Incorporated
• Inventors: Alt, Eckhard
• Primary Examiner(s): Getzow, Scott M.
• Application Number:
  US09/440,788
• Time in Patent Office: 1,016 Days
• Field of Search: 607/4, 607/5
• US Class Current: 607/4
• CPC Class Codes: A61N 1/36542 controlled by body motion, e.g. acceleration
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

An implantable medical interventional device is disclosed for treating any of multiple cardiac dysrhythmias that may be suffered by a patient in whom the device is to be implanted, by automatic selection of an appropriate therapeutic regimen from among a plurality of such regimens the device is capable of delivering according to the particular dysrhythmia being experienced by the patient at the time, through enhanced recognition and discrimination of the dysrhythmia and its probable origin. Upon recognition and discrimination of the dysrhythmia, the device applies the selected regimen to the patient'"'"'s heart to treat the dysrhythmia at its source. The device includes a DDD pacer operatively combined with an atrio-ventricular cardioverter/defibrillator, and a cardiac dysrhythmia evaluator incorporating logic responsive to cardiac signals sensed by the combined DDD pacer/cardioverter/defibrillator when the device is implanted in the patient for developing generalized findings to determine the identity and origin of a sensed dysrhythmia and to respond accordingly by selecting an appropriate therapeutic regimen to be delivered to the patient'"'"'s heart.

Claims

1. An implantable medical interventional device for treating any of multiple cardiac dysrhythmias that may be suffered by a patient in whom the device is to be implanted, by automatic selection of an appropriate therapeutic regimen from among a plurality of such regimens the device is capable of delivering according to the particular dysrhythmia being experienced by the patient at the time, through enhanced recognition and discrimination of the dysrhythmia and its probable origin, followed by application of the selected therapeutic regimen to the patient'"'"'s heart to treat the dysrhythmia at its source, said comprising:

a DDD pacer operatively combined with an atrio-ventricular cardioverter/defibrillator, and

a cardiac dysrhythmia evaluator incorporating logic responsive to cardiac signals sensed by the combined DDD pacer/cardioverter/defibrillator when said device is implanted in the patient for developing generalized findings to determine the identity and origin of a sensed dysrhythmia and to respond accordingly by selecting an appropriate therapeutic regimen to be delivered to the patient'"'"'s heart.

2. The device of claim 1, wherein said DDD pacer has rate adaptive or rate responsive capability to enable a detected tachycardia to be distinguished as physiologic or pathologic.

3. The device of claim 2, wherein said rate adaptive or rate responsive capabiltiy is provided by an accelerometer incorporated into the device.

4. The device of claim 1, wherein said logic is fuzzy logic.

5. The device of claim 1, wherein said combined DDD pacer/cardioverter/defibrillator to adapted to perform sensing, pacing and shocking respective chambers of the patient'"'"'s heart with only two leads coupled between the device and the heart.

6. The device of claim 5, wherein said two leads are a single atrial lead and a single ventricular lead.

7. The device of claim 6, wherein each of said two leads includes at least a portion composed of an electrically conductive carbon fiber material of low polarization to permit detection of intrinsic rhythm in a respective chamber of the patient'"'"'s heart despite presence of otherwise interfering polarization current on the lead.

8. The device of claim 6, wherein said single atrial lead includes a first defibrillating electrode adapted to be positioned in the right atrium and a second defibrillating electrode adapted to be positioned in the left pulmonary artery or the distal coronary sinus, when said atrial lead is implanted in the patient'"'"'s heart.

9. The device of claim 8, including a metal case housing the device and operating as an electrode for defibrillation.